Questions? Feedback? powered by Olark live chat software
Meet Our Team of Preclinical Researchers

Meet Our Team of Preclinical Researchers

With more than 100 years combined experience, Preclinical Translational Services is led by some of the nation’s top preclinical researchers and specialists.

Martha Alexander-Miller, PhD

Martha Alexander-MillerMartha Alexander-Miller, PhD, is an expert in immunity. Most recently, she is developing an influenza vaccine designed for infants younger than six months. For this research, her team established a preclinical neonatal nursery, possibly the only one in the world dedicated to translational sciences. Alexander-Miller seeks industry partners for both her discoveries and for research utilizing the capabilities of the preclinical neonatal nursery.
Full Bio / Request a Meeting

Heather DeLoid, DVM

Heather DeLoid, DVMHeather DeLoid, DVM, is an associate surgical research veterinarian in Preclinical Translational Services. She specializes in preclinical surgical services for medical device and diagnostics companies. Her areas of expertise include medical device safety and efficacy, biocompatibility and veterinary clinical care.
Full Bio / Request a Meeting

James E. Jordan, PhD

James E. JordanJames E. Jordan, has over twenty years of experience in large animal surgical models studying cardiovascular-related issues. He is currently the in vivo team leader for a project centered on a novel tissue-engineered heart valve, and places emphasis in his research on cardiovascular solutions for pediatric patient populations. Overall, Jordan offers a vast amount of expertise in utilizing surgical models and testing cardiovascular therapeutics and devices.
Full Bio / Request a Meeting

Jay R. Kaplan, PhD

Jay Kaplan, PhDJay Kaplan, PhD, directs the Wake Forest Center for Comparative Medicine Research, a leading research center that investigates diseases of human relevance. Kaplan has spent over 35 years researching the most prevalent diseases of Western society. A trained biological anthropologist, Kaplan places great emphasis on exploring and accounting for environmental factors that impact disease, such as psychosocial behavior, status and diet.
Full Bio / Request a Meeting

Vince Mendenhall, DVM, PhD

Vince Mendenhall, DVM, PhDAn internationally renowned experimental surgeon, Vince Mendenhall is known for his innovative surgical techniques, rigorous protocols and deep expertise in medical device development. Mendenhall offers over 40 years of orthopaedic surgical expertise in nearly every animal model available.
Full Bio / Request a Meeting

Michael Nader, PhD

Michael Nader, PhDMichael Nader, PhD, is a leading expert in substance abuse, who specializes in neuropharmacology. Nader has conducted research in self-administering nonhuman primates for over 30 years. Utilizing brain imaging technology and behavior techniques he can study the effects of drugs as well as ways to mitigate their effects on health.
Full Bio / Request a Meeting

Thomas B. Clarkson, DVM, DACLAM

  • Professor of Pathology – Comparative Medicine
  • One of nation’s foremost investigators in the effects of nutrition on cardiovascular disease
  • Internationally known for use of animal models to better understand human atherosclerosis
  • Research interests include coronary artery atherosclerosis and coronary heart disease in females; new directions in hormone replacement therapy; behavioral and psychosocial influences on chronic diseases; animal models
  • Past chairman of the Council on Arteriosclerosis of the American Heart Association and past president of the American College of Laboratory Animal Medicine
    Request a Meeting

Mark Cline, DVM, PhD, DACVP

  • Professor of Pathology – Comparative Medicine
  • Expertise and interest in diabetes, drugs/therapeutic agents and pharmaceuticals, infectious diseases
  • Research focusing on the effect of hormonal therapies (hormone replacement after menopause, oral contraceptives, and others) on breast and uterine cancer risk. Recent exciting results indicate that dietary soy supplementation may decrease estrogen-induced cell proliferation and cancer risk in the breast and uterus
    Request a Meeting

Kristen G. Jordan, PhD

  • Associate Director, Contract Research and Development Services
  • Scientific training and technical expertise in preclinical CNS disease/behavioral models
  • Industry research and scientific business experience spanning more than 14 years
  • Past roles as scientific project leader, laboratory manager and functional group director in a regulated drug discovery/development environment
  • Currently focused in negotiation and management of industry/sponsored contract research projects involving academic faculty at Wake Forest Medical Center.
    Request a Meeting

Diann Mendenhall

  • More than 30 years of diverse experience in the GxP medical research profession
  • Seven years of preclinical (GLP) and clinical (GCP) trial support for implantable cardiac devices
  • Four years of experience as a Quality Assurance auditor (GMP) for medical device manufacturing company auditing to FDA regulations and ISO standards
  • Six years of experience in histology field performing SEM (scanning electron microscopy) analysis
    Request a Meeting

Thomas C. Register, Ph.D.

  • Professor of Pathology – Comparative Medicine
  • Clinical Chemistry and Endocrinology Core Laboratory Director
  • Nonhuman primate biomarker development and application
    Request a Meeting

Janice D. Wagner, DVM, PhD, Diplomate ACLAM

  • Professor Emeritus of Pathology
  • Research interests in obesity, diabetes, cardiovascular disease, nutrition and women’s health research
  • Experience with protocol development for numerous preclinical drug assessments in primate models
    Request a Meeting